Your search returned the following 7 documents:

7. Deep V3 sequencing for HIV type 1 tropism in treatment-naive patients: a reanalysis of the MERIT trial of maraviroc.
   Luke C Swenson, Theresa Mo, Winnie WY Dong, Xiaoyin Zhong, Conan K Woods, Alexander Thielen, Mark A Jensen, David JHF Knapp, Douglass Chapman, Marilyn Lewis, Ian James, Jayvant Heera, Hernan Valdez, and P Richard Harrigan
   Clinical Infectious Diseases 53 (7): 732-742, 2011
   
6. Mutations in gp41 are correlated with coreceptor tropism but do not improve prediction methods substantially
   Alexander Thielen, Thomas Lengauer, Luke C Swenson, Winnie W.Y. Dong, Rachel A McGovern, Marilyn Lewis, Ian James, Jayvant Heera, Hernan Valdez, and P Richard Harrigan
   Antiviral Therapy 16 (3): 319-328, 2011
   
5. Mutations within GP41 are correlated with coreceptor tropism but do not substantially improve coreceptor usage prediction
   Alexander Thielen, Thomas Lengauer, P Richard Harrigan, Luke Swenson, Winnie WY Dong, Rachel A McGovern, Marilyn Lewis, Ian James, Jayvant Heera, and Hernan Valdez
   In: Reviews in Antiviral Therapy & Infectious Diseases, Sorrento, Italy, 2010, 47-47
   
4. Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies
   Rachel A McGovern, Alexander Thielen, Theresa Mo, Winnie Dong, Conan K Woods, Douglass Chapman, Marilyn Lewis, Ian James, Jayvant Heera, Hernan Valdez, and P Richard Harrigan
   AIDS 24 (16): 2517-2525, 2010
   
3. Screening for HIV tropism using population-based V3 genotypic analysis: a retrospective outcome analysis using stored plasma screening samples from MOTIVATE-1
   P Richard Harrigan, Rachel McGovern, Winnie Dong, Alexander Thielen, Mark Jensen, Theresa Mo, Douglas Chapman, Marilyn Lewis, Ian James, and Hernan Valdez
   In: Abstracts presented at the XVIII International HIV Drug Resistance Workshop : Basic Principles & Clinical Implications, Fort Myers, USA, 2009, A17-A17, paper no. Abstract 15.
   
2. Improved detection of X4 virus by V3 genotyping: application to plasma RNA and proviral DNA
   Andrew Moores, Alexander Thielen, Winnie Dong, Andrew J. Low, Conan Woods, Mark Jensen, Brian Wynhoven, Dennison Chan, Christopher Glascock, and P Richard Harrigan
   In: Antiviral Therapy, Sitges, Spain, 2008, A99 p.
   
1. Improved genotypic prediction of HIV-1 coreceptor usage by incorporating V2 loop sequence variation
   Alexander Thielen, P Richard Harrigan, Andrew J. Low, A Moores, Andre Altmann, Kasia Bozek, Eva Heger, Nadine Sichtig, Rolf Kaiser, and Thomas Lengauer
   In: Antiviral Therapy, Sitges, Spain, 2008, A100 p.